Molecular diagnosis of SMA—that is, loss of SMN1—has historically been made using a polymerase chain reaction (PCR)-based assay followed by digestion of the PCR product with specific restriction endonucleases (Lefebvre et al., 1995; van der Steege et al., 1995). The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.